(NASDAQ: AVR) Anteris Technologies Global's forecast annual revenue growth rate of 109.39% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.68%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.34%.
Anteris Technologies Global's revenue in 2026 is $1,851,000.On average, 6 Wall Street analysts forecast AVR's revenue for 2026 to be $685,289,109, with the lowest AVR revenue forecast at $181,251,182, and the highest AVR revenue forecast at $1,430,930,384. On average, 6 Wall Street analysts forecast AVR's revenue for 2027 to be $1,145,425,703, with the lowest AVR revenue forecast at $286,186,077, and the highest AVR revenue forecast at $2,504,128,172.
In 2028, AVR is forecast to generate $1,665,817,120 in revenue, with the lowest revenue forecast at $476,976,795 and the highest revenue forecast at $3,076,500,326.